
General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Centessa Pharmaceuticals ×
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process, with a subsidiary portfolio supported by a centralized infrastructure, asset-centric R&D model and the Centessa management team.
KGBio ×
Kalbe Genexine Biologics (“KGBio”) is an Indonesia-based joint venture between Kalbe Farma and Genexine. KGBio focuses on the in-licensing, clinical development, and manufacturing of biological products, especially in the area of immuno-oncology.
Pharvaris ×
Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition.
Chi-Med ×
Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.
CANbridge ×
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
SciNeuro ×
SciNeuro is a clinical-stage biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
Royalty Pharma ×
Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.
Adagene ×
Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
Allonnia ×
Allonnia leverages advanced technologies and biology to engineer breakthrough systems to develop and commercialize new waste remediation and management solutions.
Immunocore ×
Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and autoimmune disorders.
OcuMension ×
Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.
Motif FoodWorks ×
Motif FoodWorks is a synthetic biology company that designs and sells ingredients to companies that make plant-based foods and beverages.
PathAI ×
PathAI is a leading provider of AI-powered research tools and services for pathology.
Rubicon Research ×
Rubicon is a specialty generics pharmaceutical product-development company engaged in research, development and manufacturing of branded and specialty generic products and OTC products.
Ginkgo Bioworks ×
Ginkgo Bioworks is a synthetic biology company that designs and licenses DNA code for custom designed organisms.
Sanfer ×
Sanfer is one of the largest independent pharmaceutical companies in Mexico, operating in nine countries across Latin America.